PS1-12: Suspicious Mammogram (BIRADS 4) Outcome and Breast Biopsy: Preliminary Findings from a Cohort of 6,198 Women

Abstract

Background Annually about 1,700,000 women undergo breast biopsies with an estimated cost of $3.5 billion. About 80% of women are diagnosed with benign conditions (BCs). Other concerns are psychological impact and possible complications of radiographic evaluation of future mammograms. A recent report in the New York Times described the high rate of breast biopsies as diagnostic overkill, drastic and expensive. We report the preliminary findings on pathologic outcomes and predictive probability of sub-classifications of Breast Imaging Reporting and Data System-4 (BIRADS 4).